木瓦
微生物群
透视图(图形)
生物
免疫学
紫外线辐射
叙述性评论
微生物学
病毒学
医学
病毒
生物信息学
化学
重症监护医学
计算机科学
人工智能
放射化学
作者
Ariel Galor,Reynaldo Vargas,Ji‐Woo Kim,Karla Nelly Iruegas,Harpriya Khela,Moshe Shalom
出处
期刊:Viral Immunology
[Mary Ann Liebert, Inc.]
日期:2025-04-16
标识
DOI:10.1089/vim.2024.0074
摘要
Varicella Zoster Virus (VZV), a member of the herpes virus family, causes varicella (chicken pox) upon primary infection and later manifests as herpes zoster ([HZ] or shingles) upon reactivation. VZV-specific T-cell immunity acquired during primary infection aids recovery, with the virus lying latent in neuronal ganglia until it transports to the skin axonally during reactivation. It has been well-established that reduced T-cell recognition and proliferation, as well as immunosuppression more generally, contribute to VZV reactivation. It has also been discovered that seasonal variation, which is linked to ultraviolet radiation (UVR), correlates with increased HZ cases. This correlation may be explained by the direct immunosuppressant effects of UVR, with melanin offering photoprotective effects that decrease reactivation rates. However, an underexplored aspect of this correlation is the potential role of the skin microbiome in UVR-induced VZV reactivation. Vital for skin homeostasis and immune modulation, the skin microbiome has been found to influence various skin conditions. Preliminary evidence suggests that microbiome diversity may influence VZV reactivation rates, supported by antibiotic-induced effects on HZ incidence. Research also indicates the microbiome's modulating effect on UVR-induced immune suppression, emphasizing its potential significance in VZV reactivation. The skin microbiome's contribution may also help further explain sex and ethnicity-specific variations in VZV reactivation rates. Understanding the interplay between UVR, the skin microbiome, and VZV reactivation warrants further investigation and may help uncover preventive strategies for mitigating VZV reactivation.
科研通智能强力驱动
Strongly Powered by AbleSci AI